Proton Pump Inhibitor Use and Worsening Kidney Function: A Retrospective Cohort Study Including 122,606 Acid-Suppressing Users
No clinically relevant differences were observed for worsening kidney function between PPIs and H2-blockers initiators. PPIs users presented a reduced risk of AKI compared to ranitidine initiators.
Authors
- Luis A. Garcı́a Rodrı́guez (ORCID: https://orcid.org/0000-0003-0837-2709)
- Ángel Lanas (ORCID: https://orcid.org/0000-0001-5932-2889)
- Pablo Íñigo
- Samuel J. Martínez‐Domínguez (ORCID: https://orcid.org/0000-0003-0857-8117)
- Antonio González‐Pérez (ORCID: https://orcid.org/0000-0001-9771-5982)
Institutions
- Universidad de Zaragoza (ES)
- Hospital Universitario 12 De Octubre (ES)
- Centro Español de Investigación Farmacoepidemiológica (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- Hospital Clínico Universitario Lozano Blesa (ES)
- Instituto de Investigación Sanitaria Aragón (ES)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- Journal of General Internal Medicine
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1007/s11606-024-09213-8
- Citations
- 3
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Universidad de Zaragoza